Navigation Links
US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
Date:6/4/2009

THE WOODLANDS, Texas, June 4 /PRNewswire/ -- US Oncology, Inc. today announced that it is offering approximately $465 million aggregate principal amount of senior secured notes to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act") and outside the United States in accordance with Regulation S under the Securities Act.

The company plans to use the proceeds from the offering to refinance its senior secured credit facility which matures in quarterly installments from Sept. 30, 2010 through Aug. 20, 2011.

This notice does not constitute an offer to sell or the solicitation of an offer to buy securities. Any offers of the securities will be made only by means of a private offering memorandum. The notes have not been registered under the Securities Act, or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About US Oncology, Inc.

US Oncology, headquartered in The Woodlands, Texas works closely with physicians, manufacturers and payers to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology's expertise in supporting most aspects of the cancer care delivery system - from drug development to distribution and outcomes measurement, enables the Company to help increase the efficiency and safety of cancer care. US Oncology is affiliated with 1,227 physicians operating in 468 locations, including 95 radiation oncology facilities in 39 states. For more information, visit the Company's website, www.
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. TomoTherapy Names Rafael Vaello Vice President of Global Sales : Former Philips Healthcare executive brings proven sales experience in oncology, imaging industries
2. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
3. SearchMedicas Second Quarterly Top Clinical Search Terms Report Reveals Top 25 Oncology, General Medicine and Psychiatry Search Terms Among Medical Professionals
4. DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares
5. CorVel Announces Revenues and Earnings
6. Conceptual Options, a Center for Surrogacy & Egg Donation, Announces Third Party Assurance Program
7. Orlando Dermatology Aesthetic & Clinical (ODAC) Conference Announces Its 2010 Event
8. Synthetech Announces Fiscal 2009 Results
9. Martek Announces Second Quarter 2009 Financial Results
10. Medi-Share Program Announces New Healthcare Program Offerings for Christian Community
11. Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel...onference , San Clemente,..., maker of breakthrough medical apparel, today ann...e on display at Medica 2009, a leading internation...seldorf, Germany. Medelita inaugurates its men,s c...
(Date:11/20/2009)..., , Pioneering Neurologist Closer to Understa...Nov. 20 Dr. Jeremy Schm...School and neurologist at the Massachusetts Genera...esented his laboratory,s research on the new field...he MINDlink Foundation. ,, Dr. Schmahmann is an...
(Date:11/20/2009)... Senators and Congressmen i...ble Over their Health Care Vote , ...-- Senators and congressmen running for re-electio...olitical guru Charlie Cook, may come to regret vot...care bill, according to a breaking Zogby Internati...
(Date:11/20/2009)..., , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-...he is on a mission to redefine what it means to be...sional counselor with a specialty in family counse...Wake Forest University, Gladding says research sho...leads to sadness and even depression during the ho...
(Date:11/20/2009)...Spot blood pressure readings in children with chro...on even during doctor,s office visits increasing...ing to research from Johns Hopkins Children,s Cent...s appears online in the Journal of American Societ...pressure measurements obtained during regular doct...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...Dirk Brockmann, a theoretical physicist at the Max...on in Gottingen conducted a study which helped the...se by tracking the spread of humans with the help ...an dispersal which would help the scientist fight ...
...Cervical cancer is the second most common cancer n...e of morbidity and mortality. Early recognisation .../and help in cure and reducing mortality due to ce...uld detect early diagnosis. Women above the age of...
...The American Psychological Association (APA) has r...ress as the emphasis is on prevention during the N...percent of Americans fear that stress will have an...er time that help to manage stress in effective wa...
...Mrs. May Murphy from Glasgow was confirmed to have...dose of drugs. Mrs. Murphy was 75 years old and wa... her life very traumatic and she had painful days..... Michael Irwin and Jessica Reid. Mrs. Jessica...
...A large piece of ice is reported to have fallen fr...7 January 2006. This is reported to have taken pla... in the area.// The phenomenon has been dismissed ... The impact is reported to have created a crater w...
...Bio-functional garments like stockings with aloe v...ells like vanilla have been developed as the texti.../ This serves to give the garments an additional f...ould lead to allergic reactions. Various technique...
Other Medicine News:Health News:Tracking the spread of disease with the help of money 2Health News:Scented Garments Hit The Market 2
(Date:11/20/2009)...TH MEETING, Pa., Nov. 20 /PRNewswire-USNewswire/ -... that questions why currently available medication...eing ignored, ECRI Institute, an independent nonpr...idence on Finasteride for Prevention of Prostate ..., 2009, New York Times article, " Drugs to Deter...
(Date:11/19/2009)...HAM, Ala., Nov. 19 BioCr...nnounced the pricing of a public offering of 5,000..., resulting in gross proceeds of $48.75 million. ...rsuant to an effective shelf registration statemen...e Commission. BioCryst has also granted the under...
(Date:11/19/2009)...io, Nov. 19 Riverain Medical annou...h leading Canadian medical imaging distributor Chr...ng and OnGuard Chest Xray CAD. The exclusive agree...l,s products to the Canadian market through Christ.... ,, SoftView Enhanced Chest Imaging increases ...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Nuvo announces 2009 third quarter financial results 60283 1Nuvo announces 2009 third quarter financial results 60283 2Nuvo announces 2009 third quarter financial results 60283 3Nuvo announces 2009 third quarter financial results 60283 4Nuvo announces 2009 third quarter financial results 60283 5Nuvo announces 2009 third quarter financial results 60283 6Nuvo announces 2009 third quarter financial results 60283 7Nuvo announces 2009 third quarter financial results 60283 8Nuvo announces 2009 third quarter financial results 60283 9Nuvo announces 2009 third quarter financial results 60283 10Nuvo announces 2009 third quarter financial results 60283 11Nuvo announces 2009 third quarter financial results 60283 12Cell Biosciences Completes Acquisition of Alpha Innotech 5802 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 1Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference 5797 2
... 2008 Transdel,Pharmaceuticals, Inc. (OTC Bulleti....S. Food and Drug Administration,s ("FDA") review ... its Phase 3 clinical program for its,novel topica... ("NSAID"),Ketotransdel(TM). Transdel Pharmaceutic... the development and commercialization of non-inva...
...an Association for Dental Research Meeting, DURHA...rivately-held, development-stage pharmaceutical co...m the failure of the body,s mucosal,defenses, toda...nical,safety study of a novel sodium channel block...ssociated with primary Sjogren,s syndrome. The,pre...
Other Medicine Technology:Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 2Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 3Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 2Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment 3
... is a serum glycoprotein which binds several sex s...apacity, including testosterone and dihydrotestost...lesser extent, estradiol [1]. SHBG specifically bi...he bioavailability of sex steroids. SHBG is produc...
...elong to the transforming growth factor- (TGF-) su...f extra-cellular growth factors which control many... tumor formation (1). Other members incude TGF-s, ...n factors, AMH/MIS (Anti-Mullerian Hormone/Mulleri...
...Protein-1 (IGFBP-1) is a phosphoprotein, produced ...nd modulates the bioactivity of IGF-I and IGF-II [...fined, but the nature of its regulation suggests t...and IGF-mediated substrate utilization [1,2]. IGFB...
...gland and gonads, is the immediate precursor to bo...subsequently converted to estradiol. Androstenedio...ted at ~(less than or equal to) 20% of testosteron... exceed testosterone in both normal and disease st...
Medicine Products: